A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come

The expected launch of daraxonrasib is likely to deliver both opportunities and challenges

A scan of a patient shows a pancreatic tumor, seen in red.PNMB / SCIENCE PHOTO LIBRARY

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71.

LONDON — When researchers started planning a pancreatic cancer conference here, the aim was to simply offer a counterpart to a regular U.S. meeting, where international scientists and doctors could discuss the latest developments in the specialty.

Then came the biggest shake-up in pancreatic cancer care in decades.